UKRI invests £88 million to modernise research laboratories
UK Research and Innovation (UKRI) is investing £88 million to modernise research laboratories and expand world-leading facilities.
Long haul COVID-19 survivors experience lasting skin problems
According to a new analysis, COVID-19 patients have shown lasting skin problems long after their initial infection has cleared.
Decrease in US health insurance coverage led to 25,180 deaths
US health insurance coverage decreased significantly, resulting in 25,180 excess deaths before COVID - researchers say this number will triple if the Affordable Care Act is overturned.
COVID-19 in New York: The outbreak came from atleast 109 sources
Researchers have investigated the origins of COVID-19 in New York - from the sources that started the infection, to how it spread through the population.
NP11 launch new employment platform for the North
The North versus South narrative is currently making headlines - in the middle of the chaos, NP11 is launching a new employment platform
Research finds hydroxychloroquine does not work against COVID-19
A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.
Researchers given £2.3m to investigate the neurological impacts of COVID-19
Researchers from the University of Liverpool and King’s College London have received a £2.3 million fund from UK Research and Innovation (UKRI) to investigate the neurological impacts of COVID-19.
The ‘herd immunity’ strategy for COVID-19 is dangerous and unfeasible
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
Racial prejudice: Why Asian Americans are still blamed for COVID-19
Racial prejudice, fuelled by poor coping mechanisms and biased social media consumption, has shaped how the public view Asian Americans during the COVID-19 pandemic.
